U.S. Blindness and Visual Impairment Will Double by 2050
A study supported by RPB and the National Eye Institute and conducted by researchers at the University of Southern California (USC) Roski Eye Institute has found that the U.S. prevalence in visual impairment (VI) and blindness is expected to double over the next 35 years. By 2050, the number of Americans with a variety of eye disease and impairment issues, including age-related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR) and cataracts, will dramatically increase impacting both individuals and society.
"Individuals who are visually impaired or blind have a higher risk of chronic health conditions, unintentional injuries, social withdrawal, depression, and mortality," write the investigators.
May 20, 2016
Related News: Top Story
New study shows that diabetic eye disease is up, but the most severe forms are down
Data from an RPB and MTMVI-supported study showed that while diabetes-related eye diseases doubled since 2014, the most severe forms of the disease have decreased.
RPB Hosts Vision Research Funding Partnership 2025
Leaders of organizations that fund vision research convened in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Research to Prevent Blindness Celebrates 65 Years of Success
Since 1960, RPB has been transforming vision research and eyecare for the benefit of all people
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2025 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Maria Bartolomeo Grant, MD, is recognized for ground-breaking contributions to the field of vision research.
The Time is Now to Protect the National Eye Institute
The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.
RPB Grantees Contribute to Eye Transplantation Effort
The ARPA-H THEA project takes on an exciting challenge.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2025 Research to Prevent Blindness. All Rights Reserved.
